About
Therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2
Areas of Focus
Categories
NJ, NY, PA
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
146
By Phase
PHASE2: 1PHASE1: 1
By Status
ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06979505Lead Sponsor
GV101 in Healthy Obese Participants
PHASE2Active, not recruiting
130 participants
Started: Jun 30, 2025 · Completed: Jul 31, 2026
NCT05068947Lead Sponsor
Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy Subjects
PHASE1Completed
16 participants
Started: Sep 10, 2021 · Completed: Oct 22, 2021
Locations (1)
Headquarters
New York, NY, United States
Map
Loading map...